butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine has been researched along with Reperfusion Injury in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, L; Li, HH; Liu, ZJ; Miao, S; Wu, L; Wu, P; Wu, Q; Ye, du Y; Zou, LB | 1 |
1 other study(ies) available for butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine and Reperfusion Injury
| Article | Year |
|---|---|
Lipoxin A4 ameliorates cerebral ischaemia/reperfusion injury through upregulation of nuclear factor erythroid 2-related factor 2.
Topics: Animals; Blotting, Western; Brain; Glutathione; Heat-Shock Proteins; Heme Oxygenase (Decyclizing); Infarction, Middle Cerebral Artery; Lipoxins; Male; Neuroprotective Agents; NF-E2-Related Factor 2; Oligopeptides; Random Allocation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Sequestosome-1 Protein; Severity of Illness Index; Up-Regulation | 2013 |